Medical imaging company Neurognostics released functional data acquisition device (fDAD) Version 2.0, which the company said will enhance a user's ability to acquire functional MRI (fMRI) data. The release also includes upgraded fMRI workflow software.

The Milwaukee-based firm said fDAD 2.0’s new enhancements include: the capability to efficiently transfer fMRI exam images; an improved patient response device test; upgraded patient-specific study report; hand selection screen; consolidated archiving procedures; as well as additions to Neuorgnostic’s Stimulation Paradigm Library including new language and memory tasks.